This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HCAQ vs. KRMD, AVTX, SKIN, ACTU, SGHT, APLT, AVR, FATE, NKTX, and FTLFShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include KORU Medical Systems (KRMD), Avalo Therapeutics (AVTX), Beauty Health (SKIN), Actuate Therapeutics (ACTU), Sight Sciences (SGHT), Applied Therapeutics (APLT), Anteris Technologies Global (AVR), Fate Therapeutics (FATE), Nkarta (NKTX), and FitLife Brands (FTLF). These companies are all part of the "medical" sector. HealthCor Catalio Acquisition vs. Its Competitors KORU Medical Systems Avalo Therapeutics Beauty Health Actuate Therapeutics Sight Sciences Applied Therapeutics Anteris Technologies Global Fate Therapeutics Nkarta FitLife Brands KORU Medical Systems (NASDAQ:KRMD) and HealthCor Catalio Acquisition (NASDAQ:HCAQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk. Do insiders & institutionals believe in KRMD or HCAQ? 58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 84.2% of HealthCor Catalio Acquisition shares are owned by institutional investors. 20.6% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger earnings & valuation, KRMD or HCAQ? HealthCor Catalio Acquisition has lower revenue, but higher earnings than KORU Medical Systems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKORU Medical Systems$33.65M5.81-$6.07M-$0.09-46.94HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A Do analysts prefer KRMD or HCAQ? KORU Medical Systems currently has a consensus target price of $4.63, indicating a potential upside of 9.47%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe KORU Medical Systems is more favorable than HealthCor Catalio Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.67HealthCor Catalio Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is KRMD or HCAQ more profitable? HealthCor Catalio Acquisition has a net margin of 0.00% compared to KORU Medical Systems' net margin of -12.24%. HealthCor Catalio Acquisition's return on equity of 0.00% beat KORU Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets KORU Medical Systems-12.24% -26.77% -16.81% HealthCor Catalio Acquisition N/A N/A N/A Does the media refer more to KRMD or HCAQ? In the previous week, KORU Medical Systems had 4 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 4 mentions for KORU Medical Systems and 0 mentions for HealthCor Catalio Acquisition. KORU Medical Systems' average media sentiment score of 0.37 beat HealthCor Catalio Acquisition's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Overall Sentiment KORU Medical Systems Neutral HealthCor Catalio Acquisition Neutral SummaryKORU Medical Systems beats HealthCor Catalio Acquisition on 8 of the 12 factors compared between the two stocks. Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.64M$11.41B$6.17B$10.76BDividend YieldN/A1.84%5.72%4.83%P/E RatioN/A18.3329.8328.61Price / SalesN/A7.60500.08190.75Price / CashN/A11.9036.5560.64Price / BookN/A2.0212.016.60Net IncomeN/A$344.53M$3.32B$276.84M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$1.25+1.6%N/A+24.2%$26.64MN/A0.002High Trading VolumeKRMDKORU Medical Systems1.3542 of 5 stars$4.02-1.5%$4.63+15.0%+70.7%$185.87M$36.85M-44.6780AVTXAvalo Therapeutics2.789 of 5 stars$14.00+0.7%$31.67+126.2%+58.6%$184.10M$440K0.0040SKINBeauty Health2.592 of 5 stars$1.44-3.4%$2.81+95.3%-22.2%$182.62M$334.30M-5.141,030Positive NewsAnalyst UpgradeACTUActuate Therapeutics1.3621 of 5 stars$7.80-0.4%$20.33+160.7%-4.1%$181.30MN/A0.0010News CoverageHigh Trading VolumeSGHTSight Sciences1.9481 of 5 stars$3.45-4.2%$4.33+25.6%-3.7%$180.68M$79.87M-3.59210Analyst ForecastAPLTApplied Therapeutics3.5781 of 5 stars$1.25flat$4.13+230.0%-84.7%$180.02M$121K-2.7830AVRAnteris Technologies Global2.0317 of 5 stars$4.96+4.6%$16.50+232.7%N/A$178.86M$2.70M0.00138Positive NewsShort Interest ↑FATEFate Therapeutics4.2472 of 5 stars$1.54+0.7%$3.30+114.3%-49.8%$177.61M$13.63M-1.06550NKTXNkarta2.3569 of 5 stars$2.49-5.3%$13.50+442.2%-41.6%$176.85MN/A-1.68140FTLFFitLife Brands3.276 of 5 stars$18.69-6.7%$23.00+23.1%+17.4%$175.52M$63.05M22.2520 Related Companies and Tools Related Companies KRMD Competitors AVTX Competitors SKIN Competitors ACTU Competitors SGHT Competitors APLT Competitors AVR Competitors FATE Competitors NKTX Competitors FTLF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCAQ) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump cannot stop this trainGallup reports that two-thirds of Americans now view socialism favorably — a shocking shift that one analyst s...Porter & Company | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCAQ Stock Alerts